Reduction of the deallylation of naloxone during the storage of a naloxone-containing retard formulation
CH711429A2
A packaged pharmaceutical composition comprising a sustained release formulation of naloxone or a pharmaceutically acceptable salt thereof and a package.
DE102013013064A1
Testing and cleaning device for spray nozzles
DE102012007671A1
High active ingredient pellets
DE102011115690A1
Quetiapine-containing formulations
US2011201633A1
Alfuzosin tablets and synthesis
EP2446882A1
Medicament with improved storage stability containing the active ingredient hydromorphone